Discovery of I-0436650, a potent and selective SHP2 allosteric inhibitor for the treatment of RAS driven solid tumors. (October 2022) - Puca, F.; Fodale, V.; Randazzo, P.; Fabbrini, D.; Missineo, A.; Bisbocci, M.; Esposito, S.; Nibbio, M.; Amaudrut, J.; Colaceci, F.; Sasso, R.; Scalabrì, F.; et al.